NGKIF yields 2.16% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 8
Combined, NGKIF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NGKIF + JNJ for your $10,000?
NGK Insulators, Ltd., together with its subsidiaries, manufactures and sells electric power related equipment in Japan, North America, Europe, and Asia. The company operates through Environment Business, Digital Society Business, and Energy & Industry Business segments. It offers energy storage systems, including NAS batteries; suspension, long rod, station post, hollow, and pin post insulators; HONEYCERAM, a component for exhaust gas purification; diesel particulate filters that eliminates particulates in the exhaust gas emitted from diesel automobiles; and NOx sensors, which measures nitrogen oxide concentration in motor vehicle exhaust gas. The company also provides metal-related products, such as beryllium copper products, copper-nickel-tin alloy products, molds, and related parts; and various electronic components, such as piezoelectric micro actuators, high frequency components, and mold-cast ceramics, as well as EnerCera, a chip-type ceramic rechargeable battery. In addition, it offers ceramics for semiconductor manufacturing equipment, including ceramic heaters, electrostatic chucks, and components; and industrial process products, such as heating systems, kiln furniture and refractories, ceramic membranes and separators, glass-lining products, high temperature dust collectors, ceramic and vacuum pumps, radioactive waste treatment equipment, and gas analyzers, as well as C1 home-use water Purifiers. The company was incorporated in 1919 and is headquartered in Nagoya, Japan.
Full NGKIF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.